Literature DB >> 26312706

The role of immunohistochemistry in the Muir-Torre Syndrome.

Cláudia Marina Puga Barbosa Oliveira1, Jullyene Gomes de Campos1, Maiko Ramacos Maia1, Larissa Eva dos Santos Lobo1, Fábio Francesconi do Valle1.   

Abstract

Muir-Torre Syndrome is defined by the coexistence of sebaceous skin tumors and internal malignancies. Mutations in the DNA mismatch repair genes are found in the inherited form of the disease, resulting in the absence of crucial enzymes involved with DNA replication process. This case describes a patient with sebaceous adenoma and colorectal carcinoma, meeting the criteria for Muir-Torre Syndrome. The immunohistochemical analysis of the skin lesion was an important tool to confirm the diagnosis, as it revealed nuclear negativity for MSH2 and MSH6.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26312706      PMCID: PMC4540540          DOI: 10.1590/abd1806-4841.20153406

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient With Muir-Torre syndrome.

Authors:  Zarry Tavakkol; Jesse J Keller; Paul S Furmanczyk; Robin L Bennett; Andy J Chien
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

2.  Muir-Torre syndrome: Facts and controversies.

Authors:  Christine J Ko
Journal:  Clin Dermatol       Date:  2010 May-Jun       Impact factor: 3.541

Review 3.  Muir-Torre syndrome.

Authors:  Giovanni Ponti; Maurizio Ponz de Leon
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

Review 4.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

5.  Multiple sebaceous tumors.

Authors:  D Torre
Journal:  Arch Dermatol       Date:  1968-11

6.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

7.  Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors.

Authors:  Bonnie A Lee; Limin Yu; Linglei Ma; Anne C Lind; Dongsi Lu
Journal:  J Am Acad Dermatol       Date:  2012-04-30       Impact factor: 11.527

8.  Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.

Authors:  Micaela Mathiak; Arno Rütten; Elisabeth Mangold; Hans-Peter Fischer; Thomas Ruzicka; Waltraut Friedl; Peter Propping; Roland Kruse
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

Review 9.  The Muir-Torre syndrome: a 25-year retrospect.

Authors:  R A Schwartz; D P Torre
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

10.  Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature.

Authors:  K Tsalis; K Blouhos; K Vasiliadis; T Tsachalis; S Angelopoulos; D Betsis
Journal:  World J Surg Oncol       Date:  2006-02-08       Impact factor: 2.754

  10 in total
  1 in total

1.  Clinical Features and Association with Visceral Malignancy in 80 Patients with Sebaceous Neoplasms.

Authors:  Jee Eun Kim; Jong Hoon Kim; Kee-Yang Chung; Jin Sook Yoon; Mi Ryung Roh
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.